| Accession Number | 0001780851-26-000017 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 23, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Jul 21, 2026 | Exercise/Conversion | 284,800 | $6.55 | $1,865,440.00 | 1,304,458 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Jul 21, 2026 | Sale | 278,698 | $21.72 | $6,053,320.56 | 1,025,760 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Jul 21, 2026 | Sale | 213,702 | $22.12 | $4,727,088.24 | 812,058 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (right to buy) | Derivative | Jul 21, 2026 | Exercise/Conversion | 284,800 | $0.00 | $0.00 | 0 | Direct | โ | View Details |